Inventaire - your friends and communities are your best library

The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

এতে প্রকাশিত: The International Journal of Cardiovascular Imaging

তারিখে প্রকাশিত: 2019-03-25

Cites articles 17

তারিখ

শিরোনাম

লেখকগণ

2018-07-20

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Joanna J Wykrzykowska, Jan G. P. Tijssen
2018-07-20

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Deborah N Kalkman, Patrick W Serruys, Yoshinobu Onuma, Joanna J Wykrzykowska, Jan G. P. Tijssen, Jan J Piek, Robin P Kraak, Yohei Sotomi, Yuki Katagiri, Robbert J de Winter, Taku Asano, Carlos Collet, Martina Nassif
2018-10-12

Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)

Patrick W Serruys, Yoshinobu Onuma, Joanna J Wykrzykowska, Alexandre Abizaid, John Ormiston, Jan J Piek, Yuki Katagiri, Bernard Chevalier, Taku Asano, Carlos Collet, Ply Chichareon, Yosuke Miyazaki
2017-10-20

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

Stephen G. Ellis, Jeffrey Popma, Gregg W Stone, Dean J Kereiakes, Ronald P Caputo, Paul S. Teirstein, Annapoorna S Kini, Steven O Marx, Jan-Christopher Metzger, David G Rizik, Marc R Litt, Ameer Kabour, Robert McGreevy, ABSORB III Investigators
2017-03-29

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Joanna J Wykrzykowska, Jan G. P. Tijssen
2017-04-01

Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist's jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS?

Patrick W Serruys, Yoshinobu Onuma
2016-10-28

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Stephan Windecker, Patrick W Serruys, Dariusz Dudek, Yoshinobu Onuma, Jan J Piek, Manel Sabaté, Angel Cequier, Yohei Sotomi, Bernard Chevalier, Andrés Iñiguez, Dougal R McClean, Marcello Dominici, Steffen Helqvist, Michael Haude, Sebastian Reith, Gianluca Campo
2016-05-27

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

Patrick W Serruys, Maciej Lesiak, Irene M Lang, Yoshinobu Onuma, Joanna J Wykrzykowska, John Ormiston, Yohei Sotomi, Yuki Ishibashi, Bernard Chevalier, Carlos Macaya, Mohaned Egred, Jean Fajadet, Pannipa Suwannasom, Robbert J de Winter
2015-11-01

Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II).

Patrick W Serruys, Antonio L. Bartorelli, Yoshinobu Onuma, Alexandre Abizaid, Hector M Garcia-Garcia, John Ormiston, Maik J Grundeken, Yohei Sotomi, Yuki Ishibashi, Bernard Chevalier, Pannipa Suwannasom, Shimpei Nakatani, Robert J Whitbourn, Richard R Rapoza, Susan Veldhof
2015-10-12

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

Stephen G. Ellis, Jeffrey Popma, Gregg W Stone, Dean J Kereiakes, Ronald P Caputo, Paul S. Teirstein, Annapoorna S Kini, Steven O Marx, Jan-Christopher Metzger, David G Rizik, Marc R Litt, Ameer Kabour, Robert McGreevy, ABSORB III Investigators
2015-04-01

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

Patrick W Serruys, Antonio L. Bartorelli, Alexandre Abizaid, Bernard Chevalier, Robert J Whitbourn, Cécile C Dorange, Robert Jan M van Geuns, Ashok Seth, Marrianne Stuteville, Krishnankutty Sudhir, ABSORB EXTEND Investigators
2014-12-01

Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B T

Stephan Windecker, Patrick W Serruys, Dariusz Dudek, Yoshinobu Onuma, Hector M Garcia-Garcia, John Ormiston, Bernard Chevalier, Pieter Smit, Robert Jan M van Geuns, Shimpei Nakatani, Dougal R McClean, Jacques Koolen, Robert J Whitbourn, Richard R Rapoza, Susan Veldhof, Bernard De Bruyne, Ian T Meredith
2014-03-01

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Patrick W Serruys, Stephan Windecker, Dariusz Dudek, Yoshinobu Onuma, Hector M Garcia-Garcia, John Ormiston, Bernard Chevalier, Pieter Smit, Robert Jan M van Geuns, Dougal R McClean, Jacques Koolen, Robert J Whitbourn, Richard R Rapoza, Susan Veldhof, Bernard De Bruyne, Leif Thuesen, Ian T Meredith, Cecile Dorange, Karine Miquel-Hebert
2013-10-17

Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: rationale and study design

Pier Woudstra, Joanna J Wykrzykowska, Jan G. P. Tijssen
2013-10-01

Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A tri

Yoshinobu Onuma, Dariusz Dudek, Leif Thuesen, Mark Webster, Koen Nieman, Hector M Garcia-Garcia, Patrick W Serruys, John Ormiston
2012-11-01

ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design

Vasim Farooq, Patrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, Roberto Diletti, Bernard Chevalier, Richard R Rapoza, Susan Veldhof, Cecile Dorange, Karine Miquel-Hebert, Krishnankutty Sudhir
2011-10-05

Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold: a sub-study of the ABSORB Cohort B and the on-going ABSORB EXTEND Single Arm Study

Vasim Farooq, Josep Gomez-Lara, Antonio L. Bartorelli, Patrick W Serruys, Yoshinobu Onuma, Alexandre Abizaid, Salvatore Brugaletta, Robert Jan M van Geuns, Robert J Whitbourn, Bill D. Gogas

নিবন্ধ - wd:Q92619095

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন